The Philadelphia Business Journal reported on September 17 that pharmaceutical company GSK will construct a new biologics flex factory at its existing facility, located just outside West Conshohocken. The manufacturing facility is part of a five-year, $30 billion investment in research and supply chain infrastructure in the United States.

Construction is scheduled to start in 2026. You can find the full article here.

Photo: Google